Cargando…

The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile

Nosocomial infections are increasingly being recognised as a major patient safety issue. The modern hospital environment and associated health care practices have provided a niche for the rapid evolution of microbial pathogens that are well adapted to surviving and proliferating in this setting, aft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carter, Glen P., Douce, Gillian R., Govind, Revathi, Howarth, Pauline M., Mackin, Kate E., Spencer, Janice, Buckley, Anthony M., Antunes, Ana, Kotsanas, Despina, Jenkin, Grant A., Dupuy, Bruno, Rood, Julian I., Lyras, Dena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192846/ https://www.ncbi.nlm.nih.gov/pubmed/22022270 http://dx.doi.org/10.1371/journal.ppat.1002317

Ejemplares similares

CdtR Regulates TcdA and TcdB Production in Clostridium difficile
por: Lyon, Shelley A., et al.
Publicado: (2016)

Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures
por: van Leeuwen, Hans C., et al.
Publicado: (2013)

Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027
por: Burns, David A., et al.
Publicado: (2011)

TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630ΔErm
por: Bakker, Dennis, et al.
Publicado: (2012)

Prevalence of Hypervirulent BI/NAP1/027 Clostridium difficile Strains in Cali-Colombia
por: Rosso, Fernando, et al.
Publicado: (2017)

Clostridium difficile 027/BI/NAP1 Encodes a Hypertoxic and Antigenically Variable Form of TcdB
por: Lanis, Jordi M., et al.
Publicado: (2013)

The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview
por: Fatima, Rawish, et al.
Publicado: (2019)

Secretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdE
por: Govind, Revathi, et al.
Publicado: (2012)

Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile
por: Jabbari, Sara, et al.
Publicado: (2014)

Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile
por: Hartley-Tassell, Lauren E., et al.
Publicado: (2019)

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
por: Carter, Glen P., et al.
Publicado: (2015)

Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A
por: Murray, Ruth, et al.
Publicado: (2009)

Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile
por: Lanis, Jordi M., et al.
Publicado: (2010)

Effect of tcdR Mutation on Sporulation in the Epidemic Clostridium difficile Strain R20291
por: Girinathan, Brintha P., et al.
Publicado: (2017)

Spo0A Differentially Regulates Toxin Production in Evolutionarily Diverse Strains of Clostridium difficile
por: Mackin, Kate E., et al.
Publicado: (2013)

Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
por: Peng, Zeyu, et al.
Publicado: (2019)

First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
por: Camacho-Ortiz, Adrián, et al.
Publicado: (2015)

Correction: First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
por: Camacho-Ortiz, Adrián, et al.
Publicado: (2015)

Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model
por: Yakob, Laith, et al.
Publicado: (2015)

Risk Factors for BI/NAP1/027 Clostridioides difficile Infections and Clinical Outcomes Compared With Non-NAP1 Strains
por: Mani, Nandita S, et al.
Publicado: (2019)

Complete Genome Sequence of the Hypervirulent Bacterium Clostridium difficile Strain G46, Ribotype 027
por: Gaulton, Tom, et al.
Publicado: (2015)

748. The Changing Epidemiology of Clostridioides difficile Infection and the NAP1/027 Strain in Two Quebec Hospitals
por: Couture, Sandrine, et al.
Publicado: (2021)

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
por: Dong, Qiwen, et al.
Publicado: (2023)

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
por: Dong, Qiwen, et al.
Publicado: (2023)

Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium
por: Stabler, Richard A, et al.
Publicado: (2009)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

479. Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, New York
por: Hatwar, Trupti, et al.
Publicado: (2018)

Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection
por: Peretz, Avi, et al.
Publicado: (2016)

Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291
por: Buckley, Anthony M., et al.
Publicado: (2011)

The TcdE holin drives toxin secretion and virulence in Clostridioides difficile
por: DiBenedetto, NV, et al.
Publicado: (2023)

Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia
por: Alzahrani, Nabeel, et al.
Publicado: (2013)

Comparative biofilm-forming ability between Clostridioides difficile strains isolated in Latin America and the epidemic NAP1/027 strain
por: Morais, Maria Luana Gaudencio dos Santos, et al.
Publicado: (2022)

Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities
por: Quesada-Gómez, Carlos, et al.
Publicado: (2016)

Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
por: Hutton, Melanie L., et al.
Publicado: (2017)

Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection
por: Bosnjak, Marijana, et al.
Publicado: (2023)

Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues
por: Paparella, Ashleigh S., et al.
Publicado: (2021)

1120. Clostridium difficile Infection Risk Factors, Severity, and Outcomes in Patients Infected with NAP1/027 Strain in a Non-Epidemic Setting
por: Nahar, Julie
Publicado: (2018)

Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection
por: Kelly, Michelle L., et al.
Publicado: (2016)

A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile
por: Zhang, Bao-Zhong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mmiddtvl336rrso053q0gafoaa